Torii Pharmaceutical Co., Ltd. revised earnings guidance for the fiscal year ended December 31, 2019. In consideration of the recent trend in earnings and other factors, Torii Pharmaceutical Co. , Ltd. (Torii) has amended its full-year earnings forecasts for the fiscal year ended December 31, 2019, which were announced on October 31, 2019. The company now expects net sales of JPY 42,990 million, operating income of JPY 1,430 million, net income of JPY 27,360 million or net income per share of JPY 974.71 compared to net sales of JPY 42,700 million, operating income of JPY 700 million, net income of JPY 25,700 million or net income per share of JPY 915.62 for the same period expected previously.